AIM
🔴 AIM Plunges 5.2% as Investors React to Looming Dilutive Financings and Bankruptcy Risk
• AIM ImmunoTech Inc. is seeking stockholder approval for highly dilutive financings and a potential reverse stock split due to disclosed liquidity strain.
•...
